Receptor structure, binding, and cell entry of arenaviruses

Current Topics in Microbiology and Immunology

Volumn 262, Issue , 2002, Pages 111-137

  Kunz, S ^a   Borrow, P ^a   Oldstone, M B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; VIRUS RECEPTOR;

ARENAVIRUS; BINDING SITE; INTERNALIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS PARTICLE; VIRUS REPLICATION;

ARENAVIRUS;

EID: 0036191708     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56029-3_5     Document Type: Review

References (144)

1. Organ-specific selection of viral variants during chronic infection
2. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence
3. Analysis of heparin, alphadystroglycan and sulfatide binding to the G domain of the laminin alpha 1 chain by site-directed mutagenesis
4. Identification of the integrin VLA-2 as a receptor for echovirus 1
5. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses
6. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
7. HIV entry and tropism: The chemokine receptor connection
8. Antibodies to the vitronectin receptor (integrin alpha v beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells
9. Characterization of lymphocytic choriomeningitis virus-binding protein(s): A candidate cellular receptor for the virus
10. Mechanism of lymphocytic choriomeningitis virus entry into cells
11. Lymphocytic choriomeningitis virus
12. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression
13. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B
14. Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168→His)
15. Electron microscopic evidence for a mucin-like region in chick muscle alpha-dystroglycan
16. The N-terminal region of alpha-dystroglycan is an autonomous globular domain
17. Protein structure of lymphocytic choriomeningitis virus: Evidence for a cell-associated precursor of the virion glycopeptides
18. Protein-protein interactions in lymphocytic choriomeningitis virus
19. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering
20. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
21. Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse
22. The entry of Junin virus into Vero cells
23. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction
24. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin
25. Laminin-induced clustering of dystroglycan on embryonic muscle cells: Comparison with agrin-induced clustering
26. Laminin polymerization induces a receptor-cytoskeleton network
27. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate
28. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex
29. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex
30. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
31. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
32. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex
33. Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike
34. Competitive selection in vivo by a cell for one variant over another: Implications for RNA virus quasispecies in vivo
35. The human CD46 molecule is a receptor for measles virus (Edmonston strain)
36. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice
37. Biochemical characterization of the epithelial dystroglycan complex
38. Distribution of dystroglycan in normal adult mouse tissues
39. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2 E
40. Membrane organization of the dystrophin-glycoprotein complex
41. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
42. Purification of dystrophin from skeletal muscle
43. Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification
44. Virus-induced immunosuppression: Kinetic analysis of the selection of a mutation associated with viral persistence
45. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis
46. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
47. The role of the reovirus hemagglutinin in viral virulence
48. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin
49. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor
50. Entry of alphaherperviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor
51. Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor
52. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue
53. Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences
54. The fusion of artificial lipid membranes induced by the synthetic arenavirus "fusion peptide"
55. The major human rhinovirus receptor is ICAM-1
56. Dystroglycan versatility
57. A role for dystroglycan in basement membrane assembly
58. Dystroglycan inside and out
59. Analysis of the role of dystroglycan in early postim-plantation mouse development
60. Influenza virus haemagglutinins differentiate between receptor determinants bearing N-acetyl-N-glycollyl- and N-O-diacetylneuraminic acid groups
61. Cell membrane-associated mucins and their adhesion-modulating property
62. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily
63. The crystal structure ora laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin
64. Receptor affinities as major determinants of enterovirus tissue tropism in humans
65. The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus nucleic acid
66. Assembly of the sarcoglycan complex. Insights for muscular dystrophy
67. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer
68. Biosynthesis of dystroglycan: Processing of a precursor propeptide
69. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
70. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
71. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells
72. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan
73. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
74. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
75. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan
76. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
77. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
78. Sarcospan-deficient mice maintain normal muscle function
79. Is the acetylcholine receptor a rabies virus receptor?
80. Neural regulation of alpha-dystroglycan biosynthesis and glycosylation in skeletal muscle
81. Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies
82. The sarcoglycan complex in limb-girdle muscular dystrophy
83. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
84. Mechanism of action of cytochalasin B on actin
85. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
86. Virus entry into animal cells
87. The function of simian chemokine receptors in the replication of SIV
88. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily
89. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse
90. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
91. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta 32
92. Epstein-Barr virus enters B cells and epithelial cells by different routes
93. Human immunodeficiency virus type 1 attachment to HeLa cells is CD4 independent and gp120 dependent and requires cell surface heparans
94. Dystroglycan expression in the wild type and mdx mouse neural retina: Synaptic colocalization with dystrophin, dystrophin-related protein but not laminin
95. Co-receptors: Implications for HIV pathogenesis and therapy
96. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
97. Early events in the infection of B lymphocytes by Epstein-Barr virus: The internalization process
98. Virus receptors: Implications for pathogenesis and the design of antiviral agents
99. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure
100. Principles of viral pathogenesis
101. Virus-lymphocyte interactions III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts
102. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins
103. Proteins of LCMV: Antigenic topography of the viral glycoproteins
104. Mechanical function of dystrophin in muscle cells
105. Restoration of specific myxovirus receptors to asialoerythrocytes by incorporation of sialic acid with pure sialyltransferases
106. Structural components and replication in arenaviruses
107. How does Mycobacterium leprae target the peripheral nervous system?
108. Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain
109. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae
110. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan
111. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster
112. Entry of coxsackievirus A9 into host cells: Specific interactions with alpha v beta 3 integrin, the vitronectin receptor
113. Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction
114. Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells
115. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-)
116. Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence
117. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
118. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
119. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment
120. Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan
121. Cranin interacts specifically with the sulfatide-binding domain of laminin
122. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties
123. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics
124. Muscular dystrophies and the dystrophin-glycoprotein complex
125. Epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex
126. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins
127. The neural cell adhesion molecule is a receptor for rabies virus
128. Dystroglycan in the cerebellum is a laminin alpha 2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells
129. Structural components of the arenavirus Pichinde
130. Molecular basis of reovirus virulence: Role of the SI gene
131. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin
132. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
133. Retrovirus receptors
134. Structural basis for membrane fusion by enveloped viruses
135. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
136. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection
137. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
138. Characterization of dystroglycan-laminin interaction in peripheral nerve
139. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane
140. SH3 domain-mediated interaction of dystroglycan and Grb2
141. Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines